PHR2589
Floxuridine
pharmaceutical secondary standard, certified reference material
Manufacturer: Supelco
CAS Number: 50-91-9
Synonym(S): 5-Fluoro-2′-deoxyuridine, 2′-Deoxy-5-fluorouridine, FUDR, Floxuridine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 500 MG | PHR2589-500-MG | In Stock | ₹ 20,394.30 |
PHR2589 - 500 MG
In Stock
Quantity
1
Base Price: ₹ 20,394.30
GST (18%): ₹ 3,670.974
Total Price: ₹ 24,065.274
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to USP 1271008
description
Pharmaceutical Secondary Standard; Certified Reference Material
API family
floxuridine
form
powder
CofA
current certificate can be downloaded
packaging
pkg of 500 mg
mp
148 °C (lit.)
application(s)
pharmaceutical small molecule
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules ChemScene / Floxuridine / 1g / 794524148 / CS-1827 / 0.000 / 50-91-9 / MFCD00066758 / 246.194 / C9H11FN2O5 | -- | ₹ 2,854.28 | |
| | Sigma Aldrich Fine Chemicals Biosciences 5-Fluoro-2'-deoxyuridine thymidylate synthase inhibitor | 50-91-9 | MFCD00006530 | 1G | -- | ₹ 1,51,509.65 | |
| | Sigma Aldrich Fine Chemicals Biosciences 5-Fluoro-2′-deoxyuridine | 50-91-9 | MFCD00006530 | 100mg | -- | ₹ 29,347.08 | |
| | Matrix Scientific 5-Fluoro-2'-deoxyuridine, 50-91-9, MFCD00006530, 1g | -- | ₹ 2,921.87 | |
| | Apexbio Technology LLC Antineoplastic antimetabolite. 50-91-9. MFCD00006530 | -- | ₹ 8,042.64 | |
| | Selleck Chemical LLC Floxuridine 50mg 50-91-9 Deoxyfluorouridine, FUDR, NSC 27640 | -- | ₹ 9,959.18 | |
| | Floxuridine | -- | ₹ 46,222.75 | |
| | 5-FLUORO-2'-DEOXYURIDINE | -- | ₹ 427.80 - ₹ 53,817.24 | |
| | Floxuridine | -- | ₹ 1,197.84 - ₹ 50,138.16 | |
| | 50-91-9 | 5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione | -- | ₹ 855.60 - ₹ 58,009.68 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
- Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
- Biochem/physiol Actions: Antineoplastic drug that acts as a potent inhibitor of thymidylate synthetase Resistance to FUdR can develop in cancer cell cultures, among other means, by low-level Mycoplasma infection.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral
WGK
WGK 3